logo

Tonix Pharmaceuticals Holding Corp Inc. (TNXP) Price Performance: The Impact of Insider Trading and Institutional Holdings

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -98.51% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -96.47%. Over the past 30 days, the price of TNXP has fallen by 16.01%. And in the last five days, it has surged by 44.36%.

Tonix Pharmaceuticals Holding Corp had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $22.14 on 12/19/23, while the lowest price during the same period was $0.12 on 10/03/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of TNXP Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Tonix Pharmaceuticals Holding Corp’s current trading price is -99.13% away from its 52-week high, while its distance from the 52-week low is 62.71%. The stock’s price range for this period has been between $0.12 and $22.14. The Healthcare sector company’s shares saw a trading volume of about 46.02 million for the day, which was higher than the average daily volume of 38.62 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -47.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 33.39M and boasts a workforce of 103 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2877, with a change in price of -0.6081. Similarly, Tonix Pharmaceuticals Holding Corp recorded 31,096,262 in trading volume during the last 100 days, posting a change of -76.00%.

TNXP’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TNXP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.08.

TNXP Stock Stochastic Average

As of today, the raw stochastic average of Tonix Pharmaceuticals Holding Corp over the last 50 days is at 46.75%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 43.76%. Further, the company’s Stochastic %K and %D values for the last 20 days were 46.03% and 48.42%, respectively.

Most Popular